Diabetes Insipidus, Hypernatremia & Endocrine Crises

ABPN Neurocritical Care Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Neurologic Examination & Coma Assessment in the ICU

Current Examination, Blueprint & Preparation Neurologic Examination in Critically Ill Patients Coma Evaluation & Consciousness Alterations Delirium & Toxic-Metabolic Encephalopathy in the ICU

2 Chapter 2: Cerebral Physiology & Intracranial Dynamics

Cerebral Blood Flow, Metabolism & Autoregulation Intracranial Pressure & Compliance Cerebral Edema & Herniation Syndromes

3 Chapter 3: Intracranial Hypertension & Cerebral Perfusion Management

Tiered ICP Management Protocols Hyperosmolar Therapy & Fluid Management Advanced & Refractory ICP Interventions

4 Chapter 4: Airway, Mechanical Ventilation & Pulmonary ICU Management

Emergency Airway Management & Neuro-Intubation Mechanical Ventilation Strategies in Acute Brain Injury Tracheostomy & Ventilator Weaning in Neurocritical Care Pulmonary Complications in the Neuro-ICU Obstructive Lung Disease, Pulmonary Hypertension & Bronchoscopy

5 Chapter 5: Hemodynamics, Shock & Cardiovascular Management

Hemodynamic Monitoring & Blood Pressure Targets Vasoactive Agents: Inotropes, Vasopressors & Antihypertensives Cardiac Complications of Brain Injury

6 Chapter 6: Neuropharmacology, Analgesia & Sedation

ICU Sedation & Analgesia Neuromuscular Blockade & Monitoring Propofol Infusion Syndrome & Drug Toxicities Antiseizure Drug Pharmacology in the ICU

7 Bleeding, Thrombosis & Hematologic Emergencies

Warfarin & Heparin Reversal Direct Oral Anticoagulant (DOAC) Reversal Antiplatelet Management & Platelet Dysfunction Venous Thromboembolism Prophylaxis & Management Transfusion, Coagulopathy, TMA & Cellular-Therapy Neurotoxicity

8 Chapter 8: Systemic ICU Care, Fluids, Electrolytes & Endocrine

Hyponatremia & Osmoregulation: SIADH vs Cerebral Salt Wasting Diabetes Insipidus, Hypernatremia & Endocrine Crises Critical Care Prophylaxis, Nutrition & Infection Prevention

9 Systemic Trauma & Environmental Injury

Polytrauma, Chest Injury & Abdominal Hemorrhage Burns, Electrical Injury & Hanging

10 Cardiac Emergencies & Mechanical Support

IABP, Ventricular Devices & ECMO Acute Coronary, Valvular, Rhythm & Aortic Emergencies

11 Kidney Injury, Acid–Base & Renal Replacement

Acute Kidney Injury & Renal Drug Clearance Acid–Base Disorders, Electrolytes & Renal Replacement

12 Systemic Infection & Endocrine Emergencies

Sepsis, Endocarditis & Antimicrobial Principles Thyroid, Adrenal & Dysglycemic Emergencies

13 Gastrointestinal & Hepatic Emergencies

Acute Abdomen, GI Bleeding & Abdominal Compartment Syndrome Acute Liver Failure, Cirrhosis & Hepatic Drug Effects

14 Chapter 9: Neuroimaging in the Neuro-ICU

Non-Contrast CT & CT Angiography CT Perfusion & Advanced Perfusion Imaging Magnetic Resonance Imaging in Critical Illness

15 Chapter 10: Electrophysiology & Neuromonitoring

Continuous EEG & ACNS Standardized Critical Care Terminology Invasive Neuromonitoring: ICP & External Ventricular Drains Multimodal Monitoring: PbtO2, Microdialysis & Transcranial Doppler

16 Angiography, Electrodiagnosis & CSF Analysis

Conventional Angiography & Cranial–Spinal Shunts EMG, Nerve Conduction & Acute Muscle Disease CSF Analysis: Infection, Inflammation & Hemorrhage

17 Chapter 11: Bedside Procedures, Ultrasound & Death by Neurologic Criteria

Critical Care Procedural Skills Critical Care Ultrasound & Echocardiography Determination of Death by Neurologic Criteria

18 Chapter 12: Acute Ischemic Stroke & Reperfusion Therapies

Acute Ischemic Stroke Management & Thrombolysis Endovascular Thrombectomy & Large Vessel Occlusion Malignant Hemispheric & Cerebellar Infarction

19 Chapter 13: Spontaneous Intracerebral Hemorrhage & Intraventricular Hemorrhage

Acute Intraparenchymal Hemorrhage Management Intraventricular Hemorrhage & Hydrocephalus Surgical Evacuation & Minimally Invasive Surgery in ICH

20 Chapter 14: Aneurysmal Subarachnoid Hemorrhage & Delayed Cerebral Ischemia

Aneurysmal Subarachnoid Hemorrhage: Acute Resuscitation & Securing Delayed Cerebral Ischemia & Cerebral Vasospasm Non-Aneurysmal Subarachnoid Hemorrhage & Vascular Malformations

21 Venous, Spinal & Traumatic Vascular Disease

Cerebral Venous Thrombosis & Spinal Cord Infarction Traumatic Dissection, Carotid–Cavernous Fistula & Penetrating Injury

22 Chapter 15: Traumatic Brain & Spinal Cord Injury

Severe Traumatic Brain Injury & Contusions Acute Traumatic Spinal Cord Injury & Neurogenic Shock Spine Trauma, Fractures & Cord Syndromes

23 Chapter 16: Status Epilepticus, Seizures & Neuromuscular Emergencies

Status Epilepticus: Convulsive & Non-Convulsive Refractory & Super-Refractory Status Epilepticus Acute Neuromuscular Respiratory Failure

24 Chapter 17: Post-Cardiac Arrest Care, CNS Infections & Encephalitis

Targeted Temperature Management & Post-Cardiac Arrest Care Post-Cardiac Arrest Neuroprognostication Acute CNS Infections, Encephalitis & Inflammatory Emergencies

25 Neuroinflammation & Neurooncology

Fulminant Demyelination & Autoimmune Encephalitis Brain, Spinal & Leptomeningeal Cancer Emergencies

26 Pregnancy, Transplantation & Pediatric Care

Pregnancy, Postpartum & Post-Transplant Neurologic Care Pediatric Neurocritical Care

27 Chapter 18: Neurosurgical & Perioperative Emergencies

Postoperative Neurosurgical Complications Device Complications: EVDs, Shunts & ICP Monitors Cerebral Hyperperfusion Syndrome & Post-Interventional Emergencies

28 Chapter 19: Ethics, Palliative Care & Organ Donation in the Neuro-ICU

Communication, Surrogate Decision-Making & Conflict Resolution Neuroprognostication Ethics, Withdrawal of Life Support & Palliative Care Organ Donation & Management of the Deceased Donor

Diabetes Insipidus, Hypernatremia & Endocrine Crises

Key Takeaways Explain This Topic AI

Central DI produces inappropriately dilute polyuria; sodium may remain normal if thirst and water access compensate.

A triphasic postoperative response can occur, but many patients do not develop all three phases or follow exact day boundaries.

Free-water deficit estimates require a chosen total-body-water fraction and do not include all ongoing losses; sodium correction depends on duration and context.

Desmopressin and fluid replacement require serial sodium, urine output, and clinical assessment to avoid water intoxication or uncontrolled hypernatremia.

Suspected pituitary apoplexy with adrenal crisis requires prompt stress-dose hydrocortisone and specialist assessment; not every case requires the same surgical plan.

Last updated: October 2026

Diabetes Insipidus, Hypernatremia & Endocrine Crises

Hypernatremia ( [ Na + ] > 145 mEq/L [\text{Na}^+] > 145\text{ mEq/L} [ Na + ] > 145 mEq/L ) in the neuro-intensive care unit reflects a primary deficit of extracellular free water relative to total body sodium. In conscious individuals, hyperosmolality stimulates thirst, motivating oral water consumption to restore tonicity. In critically ill, intubated, or encephalopathic neuro-ICU patients, the thirst mechanism is incapacitated, leaving water balance entirely dependent on physician-directed fluid therapy. Severe hypernatremia ( [ Na + ] > 155 – 160 mEq/L [\text{Na}^+] > 155\text{--}160\text{ mEq/L} [ Na + ] > 155 – 160 mEq/L ) induces cellular brain dehydration, shrinking cerebral cortical volume, stretching fragile bridging veins (causing subdural or subarachnoid hemorrhage), and generating encephalopathy, tremors, myoclonus, and seizures.

Neuroanatomy of AVP Synthesis & Etiologies of Central DI

Central Diabetes Insipidus ( C D I CDI C D I ) is caused by a deficiency in the synthesis, axonal transport, or neurohypophyseal secretion of arginine vasopressin ( A V P AVP A V P ). Magnocellular neurons residing in the hypothalamic supraoptic ( S O N SON SON ) and paraventricular ( P V N PVN P V N ) nuclei synthesize the preprohormone prepropressophysin. Following post-translational processing into A V P AVP A V P and neurophysin II, the hormone travels down unmyelinated axons through the infundibulum (pituitary stalk) and terminates on fenestrated capillaries in the posterior pituitary lobe (neurohypophysis).

Critical Anatomic Localization

Infundibular Stalk or Posterior Lobe Lesions: Lesions located below the median eminence (such as intrasellar surgery or low stalk manipulation) spare the hypothalamic neuronal somata. In many cases, severed proximal axon terminals in the median eminence undergo reorganization, forming a functional "pseudo-posterior lobe" that can secrete basal AVP, resulting in transient or resolving DI.

Supra-infundibular Hypothalamic Lesions: Direct destruction of the supraoptic and paraventricular nuclei or high stalk transection at or above the median eminence causes retrograde neuronal apoptosis, resulting in permanent, irreversible central diabetes insipidus.

Primary Etiologies in the Neuro-ICU

Neurosurgical Intervention: Transsphenoidal resection of pituitary adenomas, craniopharyngiomas, Rathke cleft cysts, or anterior skull base meningiomas.

Severe Traumatic Brain Injury: Basal skull fractures extending through the sella turcica, clivus, or sphenoid sinus; shearing injury of the infundibular stalk from severe rotational deceleration.

Cerebral Circulatory Arrest / Brain Death: Transtentorial and tonsillar herniation compresses the anterior and posterior hypophyseal arteries, leading to ischemic necrosis of the pituitary gland and hypothalamus. Central DI develops in over 80 % 80\% 80% of brain-dead organ donors.

Inflammatory & Infiltrative Diseases: Lymphocytic hypophysitis, sarcoidosis, Langerhans cell histiocytosis, and fungal or tuberculous meningitis.

Diagnostic Criteria for Central Diabetes Insipidus

The bedside diagnosis of central DI requires confirming polyuria coupled with an inability to concentrate the urine despite hypertonicity:

Severe Polyuria: Urine output > 4 – 5 mL/kg/h > 4\text{--}5\text{ mL/kg/h} > 4 – 5 mL/kg/h or > 250 – 300 mL/h > 250\text{--}300\text{ mL/h} > 250 – 300 mL/h for at least 2 consecutive hours (often exceeding 5 – 10 L/day 5\text{--}10\text{ L/day} 5 – 10 L/day in severe cases).

Hypernatremia & Hyperosmolality: Serum [ Na + ] > 145 mEq/L [\text{Na}^+] > 145\text{ mEq/L} [ Na + ] > 145 mEq/L (frequently > 150 – 160 mEq/L > 150\text{--}160\text{ mEq/L} > 150 – 160 mEq/L ) and plasma osmolality > 300 mOsm/kg > 300\text{ mOsm/kg} > 300 mOsm/kg .

Inappropriately Dilute Urine: Urine osmolality < 200 – 300 mOsm/kg < 200\text{--}300\text{ mOsm/kg} < 200 – 300 mOsm/kg (often < 100 – 150 mOsm/kg < 100\text{--}150\text{ mOsm/kg} < 100 – 150 mOsm/kg ) and urine specific gravity < 1.005 < 1.005 < 1.005 .

Differentiating Central DI from Osmotic Diuresis

In the neuro-ICU, polyuria often results from osmotic diuresis induced by hyperosmolar therapies (mannitol, 3 % 3\% 3% hypertonic saline) or severe hyperglycemia. Differentiating CDI from osmotic diuresis is critical:

In osmotic diuresis , total urinary solute excretion is elevated ( > 60 mOsm/h > 60\text{ mOsm/h} > 60 mOsm/h ), and urine osmolality is typically iso-osmolar or hyperosmolar to plasma (usually > 300 – 400 mOsm/kg > 300\text{--}400\text{ mOsm/kg} > 300 – 400 mOsm/kg ). In addition, urinary glucose or urea is markedly elevated.

In central DI , urinary solute excretion is normal, but the urine is profoundly hypotonic ( < 200 mOsm/kg < 200\text{ mOsm/kg} < 200 mOsm/kg ) due to defective water reabsorption.

The Classic Triphasic Response After Pituitary Stalk Injury

Following surgical manipulation, transection, or blunt traumatic shearing of the pituitary stalk, patients can exhibit a triphasic response , although it is not the usual course in every patient over a 2- to 3-week postoperative course: Timeline: [ Days 1 – 5 ] -----> [ Days 6 – 10 ] -----> [ > Day 10 ]

• Phase: Phase 1 Phase 2 Phase 3
• Condition: Acute DI SIADH-like Permanent DI
• Mechanism: Axonal shock / Unregulated AVP AVP depletion /
• Stunned neurons leakage from axons neuronal death
• Findings: Polyuria, hyper-Na+ Oliguria, hypo-Na+ Polyuria, hyper-Na+
• Detailed Phases

Phase 1: Acute Diabetes Insipidus (Days 1–5): Mechanical shock, ischemia, and edema stun the hypothalamic magnocellular neurons and pituitary stalk. A V P AVP A V P synthesis and transport halt abruptly. The patient develops profound hypotonic polyuria, rapid free water loss, rising serum sodium, and hyperosmolality.

Phase 2: Intercurrent SIADH-like State (Days 6–10): As injured axons within the disconnected posterior pituitary lobe undergo Wallerian degeneration and autolysis, preformed neurosecretory granules rupture. Stored A V P AVP A V P leaks uncontrollably into the systemic circulation without osmotic or baroreceptor regulation. The patient transitions abruptly into an antidiuretic state characterized by oliguria, inappropriately concentrated urine, and precipitously plunging serum sodium.

Phase 3: Permanent Diabetes Insipidus (After Day 10): Preformed stores of A V P AVP A V P within the degenerating neurohypophysis become completely exhausted. If the underlying hypothalamic magnocellular somata were irreversibly destroyed, the patient enters a permanent state of central DI requiring lifelong desmopressin therapy. If sufficient hypothalamic neurons survived, the triphasic response may truncate after Phase 2, resolving into normal water balance.

Warning

Catastrophic DDAVP Prescribing Pitfall: Administering desmopressin on a fixed, standing schedule (e.g., 1 μ g 1\text{ }\mu\text{g} 1 μ g IV every 12 hours) during Phase 1 is a frequent clinical trap. When the patient naturally transitions into Phase 2 on days 6 to 10, the combination of exogenous DDAVP and endogenous AVP leakage triggers catastrophic water retention, massive hypo-osmolar cerebral edema, status epilepticus, and fatal uncal herniation. Always prescribe desmopressin strictly on a PRN breakthrough basis .

• Quantitative Management: Free Water Replacement & DDAVP Titration
• 1. Calculation of Free Water Deficit (FWD)

To replace accumulated free water losses safely, calculate the Free Water Deficit: FWD = Total Body Water (TBW) × ( [ Na + ] 140 − 1 ) \text{FWD} = \text{Total Body Water (TBW)} \times \left( \frac{[\text{Na}^+]}{140} - 1 \right) FWD = Total Body Water (TBW) × ( 140 [ Na + ] ​ − 1 )

Where Total Body Water ( T B W TBW TB W ) is calculated as:

• Non-elderly males: 0.60 × weight (kg) 0.60 \times \text{weight (kg)} 0.60 × weight (kg)
• Non-elderly females: 0.50 × weight (kg) 0.50 \times \text{weight (kg)} 0.50 × weight (kg)

Elderly males: 0.50 × weight (kg) 0.50 \times \text{weight (kg)} 0.50 × weight (kg) ; Elderly females: 0.45 × weight (kg) 0.45 \times \text{weight (kg)} 0.45 × weight (kg)

2. Fluid Administration Strategy

Rate of Correction: Lower serum sodium at a controlled rate of ≤ 10 – 12 mEq/L \le 10\text{--}12\text{ mEq/L} ≤ 10 – 12 mEq/L per 24 hours (approximately 0.5 mEq/L/h 0.5\text{ mEq/L/h} 0.5 mEq/L/h ). Rapid overcorrection of chronic hypernatremia causes acute intracellular water influx, precipitating lethal cerebral edema and seizures due to intracellular idiogenic osmoles accumulated by brain cells during hypertonicity.

Fluid Replacement Components: Total fluid administered per hour must equal: Hourly FWD correction + Ongoing insensible losses ( ≈ 30 – 40 mL/h) + Ongoing free water urinary loss \text{Hourly FWD correction} + \text{Ongoing insensible losses (}\approx 30\text{--}40\text{ mL/h)} + \text{Ongoing free water urinary loss} Hourly FWD correction + Ongoing insensible losses ( ≈ 30 – 40 mL/h) + Ongoing free water urinary loss .

Route of Administration: The enteral route (sterile water via nasogastric or feeding tube) is preferred because it avoids hyperglycemia and osmotic diuresis. If the patient cannot tolerate enteral water, intravenous 5 % 5\% 5% dextrose in water ( D 5 W D_5W D 5 ​ W ) or hypotonic saline ( 0.2 % 0.2\% 0.2% or 0.45 % 0.45\% 0.45% NaCl) is infused.

3. Pharmacotherapy: Desmopressin (DDAVP)

Mechanism: Desmopressin (1-deamino-8-D-arginine vasopressin) is a synthetic analog of A V P AVP A V P with potent, selective affinity for V 2 V_2 V 2 ​ antidiuretic receptors ( V 2 : V 1 V_2:V_1 V 2 ​ : V 1 ​ selectivity ratio > 2000 : 1 > 2000:1 > 2000 : 1 ), providing maximal antidiuresis without V 1 V_1 V 1 ​ -mediated arterial vasoconstriction.

Dosing & Administration: In acute CDI, administer 0.5 – 2.0 μ g 0.5\text{--}2.0\text{ }\mu\text{g} 0.5 – 2.0 μ g IV or subcutaneously (or 0.1 – 0.2 mg 0.1\text{--}0.2\text{ mg} 0.1 – 0.2 mg enterally). The onset of action is 15–30 minutes, with duration lasting 6 to 12 hours.

Bedside Titration Protocol: Target a manageable urine output of 100 – 200 mL/h 100\text{--}200\text{ mL/h} 100 – 200 mL/h . Withhold subsequent doses until breakthrough polyuria recurs ( > 250 – 300 mL/h > 250\text{--}300\text{ mL/h} > 250 – 300 mL/h for 2 consecutive hours with urine specific gravity < 1.005 < 1.005 < 1.005 ). Monitor serum sodium and urine specific gravity every 4 to 6 hours.

• Pituitary Apoplexy & Endocrine Crises
• Pathophysiology of Pituitary Apoplexy

Pituitary apoplexy is an acute neurosurgical and endocrine emergency caused by sudden ischemic infarction or hemorrhage of a preexisting pituitary adenoma (macroadenoma > 10 mm > 10\text{ mm} > 10 mm ). Because rapidly expanding adenomas outgrow their hypophyseal portal blood supply, vascular compression against the diaphragmatic notch precipitates hemorrhagic necrosis.

Precipitating triggers include major surgery (especially coronary artery bypass grafting), severe arterial hypertension, dynamic pituitary function testing (TRH, GnRH), bromocriptine therapy, head trauma, and systemic anticoagulation.

Clinical Presentation: The Apoplexy Triad

Severe Headache: Sudden-onset, catastrophic "thunderclap" retro-orbital, frontal, or bifrontal headache, frequently mimicking aneurysmal subarachnoid hemorrhage.

Neuro-Ophthalmic Emergencies:

Optic Chiasm Compression: Superior expansion through the diaphragma sellae compresses the optic chiasm, producing acute visual acuity loss and classic bitemporal hemianopsia .

Cavernous Sinus Compression: Lateral expansion compresses cranial nerves running through the cavernous sinus, producing unilateral or bilateral ophthalmoplegia: oculomotor (CN III; ptosis, fixed dilated pupil, "down-and-out" eye), trochlear (CN IV), and abducens (CN VI) palsies, along with trigeminal sensory loss in V 1 V_1 V 1 ​ and V 2 V_2 V 2 ​ distributions.

Acute Panhypopituitarism & Adrenal Crisis: Destruction of the anterior pituitary corticotrophs halts adrenocorticotropic hormone ( A C T H ACTH A CT H ) production. The resulting acute secondary adrenal insufficiency causes profound cortisol deficiency, manifesting with intractable hypotension, vasopressor-refractory shock, hypoglycemia, and coma.

Important

Immediate Glucocorticoid Replacement: The primary threat to survival in acute pituitary apoplexy is adrenal crisis and cardiovascular collapse. Stress-dose glucocorticoid therapy must be administered immediately upon clinical suspicion, prior to imaging and prior to surgical intervention. Administer hydrocortisone 100 mg 100\text{ mg} 100 mg IV bolus , followed by 100 mg 100\text{ mg} 100 mg IV every 8 hours (or a continuous infusion of 200 – 300 mg/day 200\text{--}300\text{ mg/day} 200 – 300 mg/day ). If dynamic endocrine testing is pending, dexamethasone ( 4 mg 4\text{ mg} 4 mg IV q6h) can be substituted because it does not interfere with serum cortisol immunoassays.

Urgent Surgical vs. Conservative Management

Emergent Transsphenoidal Decompression: Indicated within 24 to 48 hours for patients with acute severe visual acuity loss, progressive visual field deficits, deteriorating consciousness, or unresponsiveness to medical resuscitation.

Conservative Medical Management: May be considered in hemodynamically stable patients with mild, non-progressive cranial nerve palsies without visual acuity or visual field impairment, managed with stress-dose corticosteroids and close neuromonitoring.